FI873879A - Lymfocyter aktiverande polypeptider. - Google Patents

Lymfocyter aktiverande polypeptider. Download PDF

Info

Publication number
FI873879A
FI873879A FI873879A FI873879A FI873879A FI 873879 A FI873879 A FI 873879A FI 873879 A FI873879 A FI 873879A FI 873879 A FI873879 A FI 873879A FI 873879 A FI873879 A FI 873879A
Authority
FI
Finland
Prior art keywords
lymfocyter
aktiverande
polypeptider
lymfocyter aktiverande
aktiverande polypeptider
Prior art date
Application number
FI873879A
Other languages
English (en)
Other versions
FI873879A0 (fi
Inventor
William Oliver Weigle
Monte O Hobbs
Edward L Morgan
Marilyn L Thoman
Richard A Houghten
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of FI873879A0 publication Critical patent/FI873879A0/fi
Publication of FI873879A publication Critical patent/FI873879A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/866Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving immunoglobulin or antibody fragment, e.g. fab', fab, fv, fc, heavy chain or light chain
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/14Lymphokine; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI873879A 1986-01-09 1987-09-08 Lymfocyter aktiverande polypeptider. FI873879A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/817,526 US4683221A (en) 1986-01-09 1986-01-09 Lymphocyte-activating polypeptides
PCT/US1987/000052 WO1987004073A1 (en) 1986-01-09 1987-01-09 Lymphocyte-activating polypeptides

Publications (2)

Publication Number Publication Date
FI873879A0 FI873879A0 (fi) 1987-09-08
FI873879A true FI873879A (fi) 1987-09-08

Family

ID=25223275

Family Applications (1)

Application Number Title Priority Date Filing Date
FI873879A FI873879A (fi) 1986-01-09 1987-09-08 Lymfocyter aktiverande polypeptider.

Country Status (7)

Country Link
US (1) US4683221A (fi)
EP (1) EP0253873A4 (fi)
JP (1) JPS63502347A (fi)
AU (1) AU591243B2 (fi)
DK (1) DK467087A (fi)
FI (1) FI873879A (fi)
WO (1) WO1987004073A1 (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4844895A (en) * 1985-11-01 1989-07-04 New York University Composition containing a peptide fragment of platelet factor four and method for restoring suppressed immune responses
IT1190433B (it) * 1985-12-11 1988-02-16 Prodotti Antibiotici Spa Peptidi correlati al lisozima
EP0284898A3 (de) * 1987-04-02 1990-06-27 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Hinge-Peptid, Verfahren zu seiner Herstellung und seine Verwendung zur Herstellung synthetischer Immunogene
AU4809097A (en) * 1996-10-21 1998-05-15 Mark E. Howard Peptides for inhibiting retroviruses
WO2000029009A1 (en) * 1998-11-18 2000-05-25 Coastside Bio Resources Peptides having anti-cancer and anti-inflammatory activity
KR101692275B1 (ko) * 2010-02-11 2017-01-04 노오쓰웨스턴 유니버시티 2차 구조 안정화된 nmda 수용체 조절제 및 그의 용도
SG10201501050RA (en) 2010-02-11 2015-04-29 Univ Northwestern Secondary Structure Stabilized NMDA Receptor Modulators And Uses Thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4415493A (en) * 1982-05-11 1983-11-15 Scripps Clinic And Research Foundation Immune modulator peptides
US4579840A (en) * 1983-08-12 1986-04-01 Immunetech Pharmaceuticals Method of blocking immune complex binding to immunoglobulin Fc receptors

Also Published As

Publication number Publication date
US4683221A (en) 1987-07-28
JPS63502347A (ja) 1988-09-08
EP0253873A1 (en) 1988-01-27
EP0253873A4 (en) 1990-06-26
FI873879A0 (fi) 1987-09-08
AU6938987A (en) 1987-07-28
WO1987004073A1 (en) 1987-07-16
AU591243B2 (en) 1989-11-30
DK467087D0 (da) 1987-09-08
DK467087A (da) 1987-09-08

Similar Documents

Publication Publication Date Title
ATE70057T1 (de) Antitumormittel.
DE3775679D1 (de) Vernebler.
DE3767169D1 (de) Sportschuh.
ATE57924T1 (de) 3-aryloxy-3-substituierte-propanamine.
DE3764043D1 (de) Alkylendiamine.
ATE63533T1 (de) Xylolisomerisierung.
DE3779761D1 (de) Abseilgeraet.
DE3785294T2 (de) Neigungsmesser.
DE3771918D1 (de) Chinolinamide.
DE3786679D1 (de) Schmitt-triggerschaltung.
DE3773636D1 (de) Saeurebeschleunigte hydrocarboxilierung.
DE3771271D1 (de) Fluorphthalimide.
FI860054A0 (fi) Motionsanordning.
DE3779382D1 (de) 3-6-diphenylpyridazine.
DE3763648D1 (de) Rollski.
FI873879A (fi) Lymfocyter aktiverande polypeptider.
FI860046A0 (fi) Foerlaengningsanordning foer traefaner.
DE3669032D1 (de) Okulopressionsgeraet.
DE3766410D1 (de) Methylalkylcyclosiloxane.
DE3764485D1 (de) Polyglycidylamine.
DE3770459D1 (de) 3-halogensuccinimide.
FI860072A (fi) Mataranordning foer en spannmaolstork.
DE3781179T2 (de) Acyl-coa-synthetase.
FI73944B (fi) Rullningsanordning foer pappersbana.
FI77950B (fi) Foergreningsklaemma foer en sektorformig kapad huvudledning.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: SCRIPPS CLINIC AND RESEARCH FOUNDATION